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Introduction
Populations around the world are ageing faster than 
ever in the past. A constant and already impressive rate 
in the worldwide increase of life expectancy has led to 
the fact that the current proportion of the population 
above 60 years (17%) will double in the next thirty to 
forty years. In the next 30 years, every third person in 
the world will fall into the category of a senior citizen. 
This demographic transition will have an impact on 
almost all aspects of society and requires a complete 
and well-defined shift in the paradigm in the medical, 
social, and technological fields.
Croatia’s Presidency of the Council of the European 
Union 2020 highlighted demographic challenges and 
ageing as important issues. Under the Horizon 2020 
Work Programme Health, demographic change and 
wellbeing 2018–2020 call 10 within the section “Other 
actions”, a conference Better Future of Healthy Ageing 
2020 (BFHA 2020) took place as a part of “Croatian 
Presidency event – Innovation for better ageing”, orga-
nized by the University of Zagreb School of Medicine at 
the Andrija Štampar School of Public Health.
The conference addressed growing demand caused 
by global trends of population ageing and the expan-
sion of chronic disease by focusing on potentials large-
scale implementation of innovations to foster func-
tional ability and wellbeing of older people. The objec-
tives of the conference were:
1.  to address issues of ageing of biological systems 
through the topics of regenerative medicine, 
neuroscience, clinical medicine, and other fields 
of medicine with the emphasis on personalized 
and integrated medicine;
2.  to showcase the impact of smart technologies 
for age friendly ecosystems by providing a dis-
cussion on scaling up innovations and solutions 
for age-friendly environments;
3.  to analyse the issues of ageing and healthcare 
system sustainability at various levels (e.g. insti-
tutional, regional, state, EU level).
Based on the three objectives the conference Better 
Future of Healthy Ageing 2020 (BFHA 2020) was di-
vided into three main themes:
•	  Ageing of Biological Systems
•	  Smart Technologies for Age Friendly Ecosys-
tems
•	  Ageing and Health System Sustainability
This paper is a result of the conference discussions. 
This paper aims to present the current state of the art 
in the three themes discussed during the conference 
and to raise questions important for future discussion 
within the EU concerning healthy ageing. It will also 
set out specific goals within each of the three teams 
and mechanisms for possible actions their monitoring 
to promote accountability in future discussions within 
the EU.
Ageing of Biological Systems
Ageing, although highly individual and not easily 
comparable among subjects and societies, is a major 
risk factor for age-related conditions and is causal to 
many age-related diseases including COPD, cardio-
vascular disease, neoplasms, osteoporosis, rheumatoid 
arthritis, cataract and Alzheimer’s disease.
There is good evidence, shown in animal models 
and recent clinical studies in humans, that ageing is a 
risk factor and decelerating ageing has the potential to 
decrease risks of developing the disease. These ap-
proaches include maintaining body composition (re-
ducing obesity), good nutrition (less meat, more fruits 
and vegetables, e.g. Mediterranean diet), more exer-
cise, healthy sleep habits, moderate alcohol consump-
tion (glass of red wine taken with a meal), intake of 
probiotics.
From the biological point of view, it is challenging to 
link age-related diseases to general principles of age-
ing, which means that discovering approaches to de-
crease the rate of protein damage could have beneficial 
effects on all age-related diseases including COPD, 
cardiovascular disease, neoplasms, osteoporosis, rheu-
matoid arthritis, cataract and Alzheimer’s disease.
Ageing can be accelerated or decelerated by interfer-
ing at the cellular level with several mechanisms driv-
ing ageing including the accumulation of excessive 
DNA damage or misfolded protein or cells which have 
aged and are no longer functional but release inflam-
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matory factors which are detrimental to the organisms 
(senescent cells). By decelerating ageing, it is possible 
to reduce the risks of developing age-related diseases 
and improve health span.
European Brain Council estimates that in Europe 
the total cost of brain diseases on a yearly basis 
amounts to around 798 billion euro; for dementia only, 
the cost is 22.000 euro per patient, per year. Consider-
ing the costs of dementia for the European society and 
that these costs will increase considerably in the com-
ing years due to the ageing of the European popula-
tion, one way of curbing this increase and eventually 
decreasing the costs is via intensified research. Only by 
improving the insight into the basic functioning of the 
brain and translating this knowledge to the disease 
state, understanding the causes of the disease process 
and paving the way for better targeted and improved 
treatment can the upwards spiral of the costs of brain 
disorders can be stopped.
Particularly there is the need to emphasize the im-
portance of raising awareness and encouraging educa-
tion on the brain and the repercussions of neurological 
and mental health conditions on society as a whole 
considering that the vast majority of brain disorders 
are strongly influenced by an ageing population, where 
an increase in healthy ageing is desired.
Ischemic heart disease (IHD) is a major cause of 
morbidity and mortality among older persons, as the 
age represents the strongest risk factor for the develop-
ment of the atherosclerotic changes along the arterial 
tree. Older patients often have an atypical clinical pre-
sentation and more complications. Stated facts leave 
for the task on future trials to involve more elderly in 
their investigations, therefore pathophysiology, pre-
sentation and treatment can be better understood.
Rheumatic diseases are a prevalent group of entities 
with a significant impact on the quality of life and 
morbidity in older persons. Adequate timing of con-
temporary treatment that is available can lead to pre-
vention of disability; decline in sick leave, prolonga-
tion of time actively spent at work, as well as increased 
survival.
Neoplastic diseases are, having some exceptions in 
the field of hemato- and neuropathology, by far more 
common in older people. The theoretical basis of this 
is wide, not always well defined by clearly including 
the passing of time as one of the key factors. Sophisti-
cated technologies are today opening widely the field 
of multigene testing, meanwhile also opening the 
question of rationalizing diagnostic efforts.
Sleep is the state at which we spend around one-
third of our life. It is not the only duration of sleep that 
is linked to increased morbidity and mortality like in 
chronic sleep deprivation and insomnia but also sleep 
quality which is reduced in many sleep disorders. Cer-
tain sleep disorders are strongly associated with age 
and so prevalent in older populations being present in 
50% or more people. They are also strongly associated 
with the most prevalent diseases of today such as de-
mentia, cardiovascular diseases, and hypertension, as 
well as diabetes. Intermittent hypoxia during sleep in 
Obstructive Sleep Apnea (OSA) patients is a major 
concern in sleep medicine of today and it is highly 
prevalent but treatable sleep breathing disorder whose 
treatment is one of the strongest possible prevention 
measures which may help in securing healthy ageing 
by preventing some of the major causes of death in this 
age, such as stroke, myocardial infarction, arrhyth-
mias, diabetes, etc.
Ageing is a risk factor for frailty, a common clinical 
syndrome in older adults, defined as an accumulation 
of deficits and loss of resilience to adverse events and 
increased risk for poor health outcomes including in-
cident disability, higher hospitalization, and mortality 
rate. There is evidence that by targeting mechanisms 
such as senescence it prevents or reduces frailty and 
improves the ability to overcome adverse events such 
as fractures and infections.
Policies that will support the testing in clinical trials 
with a new class of drugs and integrate their use with 
existing public health interventions are required. There 
are many issues with establishing clinical testing for 
drugs targeting ageing in older patients with multiple 
chronic conditions. This group of people is often ex-
cluded or under-represented in drug testing trials. Due 
to the lack of knowledge and a clear route to market 
pharmaceutical companies do not invest in the testing 
of these drugs and therefore governmental funding is 
required to risk their investments and open a new mar-
ket which will bring both better health and great eco-
nomic benefit and competitiveness in Europe.
The time and cost of current clinical trials in hu-
mans delay the delivery of innovative medicines to 
those in need. The EU, working with national govern-
ments, has an opportunity to reduce the time and cost 
of European and global trials by encouraging Euro-
wide mechanisms for ethical reviews of drug proto-
cols, by innovating digital means of recruiting and 
testing trial participants and by linking European trial 
support mechanisms with those in other regions of the 
world (e.g., the European Prevention of Alzheimer’s 
Dementia partnership with the North American Glob-
al Alzheimer’s Platform).
It is important not only to focus on an already aged 
population but also on those who will inevitably enter 
this stage. Ageing is a continuous process starting in 
utero, and interventions should be focused across the 
life course. There is a clear need for the medicine of the 
21st century to focus not only on persons with existing 
problems but also to shift its focus to presently healthy 
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individuals who are soon entering the senior category. 
Similarly to focus on preventing certain diseases by 
applying standards of health promotion such as a 
healthy diet and exercise, we need to become aware of 
the need for programmes that will move us into pursu-
ing the goal of healthy ageing in all its elements. These 
should include prevention of injuries, an individual 
approach to cognitive and mental health, prevention 
of chronic diseases, and general social engagement.
It is possible to decelerate ageing with public health 
interventions such as exercise and a healthy diet but 
also with the development of new drugs which have 
the potential to prevent multiple age-related condi-
tions and improve the resilience of the older popula-
tion. COVID-19 pandemic is an excellent example of 
how interventions improving resilience may protect 
older people from death.
Furthermore, there is a constant need for strength-
ening the information flow and accelerating the ex-
change of experience on the on-going and future proj-
ects as well as maintaining continuous dialogue be-
tween all the stakeholder groups at the national and 
European level and initiatives to allow that objectives 
are aligned, and needs are met.
Smart Technologies  
for Age Friendly Ecosystems
Modern Information and Communication Technol-
ogies (ICTs) can play a key part in helping older people 
to lead more independent and healthy lives and to im-
prove social participation. Age-friendly technologies 
and ecosystems allow older people to live indepen-
dently, monitor their health, create and maintain so-
cial networks, stay in contact with friends and family, 
have access to goods and services, and engage in work 
or voluntary activities. Smart ICT solutions and ad-
vanced artificial intelligence (AI) implemented in 
homes, communities, and cities can be used to provide 
personalized healthcare and social services, solutions 
to overcome lack of mobility, cognitive and visual 
problems. They also can improve the general quality of 
life by providing interactions with family, friends as 
well as health care and social care providers through 
telehealth. Digital technologies can encourage all 
groups of patients, and older persons, to take a more 
active role in their health management.
Regarding the scientific approach to ageing research, 
we must improve measurement, monitoring, and un-
derstanding of that field. Focused research, new met-
rics, and analytical methods are needed for a wide 
range of ageing issues. This work builds on the exten-
sive work WHO has done in improving health statis-
tics and information, for example through the WHO 
Study on global ageing and adult health (SAGE). The 
examples of proven and good practices of using ad-
vanced technologies to increase the functionality and 
well-being of ageing citizens will contribute to a deep-
er understanding of how to adopt and implement 
these proven good practices in various European and 
International contexts.
Smart technologies and the data collection related to 
the use of these tools could be a powerful research en-
gine for age-related conditions and to advance healthy 
ageing. Consider Alzheimer’s disease as an example. 
Increasingly, the research community is developing 
evidence that indicates that cognitive and motor 
changes may occur before symptoms. Smart technol-
ogy and digital tools may be best suited to detect cog-
nitive decline in the earliest stages of the disease. To 
advance the opportunity, there should be broad col-
laboration in the identification of readily accessible 
digital biomarkers to advance digital phenotyping 
with a plan to develop, test and implement new tech-
nologies. One possible centre for collaboration could 
be with the Davos Alzheimer’s Collaborative, being led 
by The Global CEO Initiative on Alzheimer’s Disease 
and The World Economic Forum. The development of 
digital phenotyping for Alzheimer’s would also sup-
port other areas of research focusing on ageing.
Addressing the issues of tracing and assessing the 
use and impact of advanced technologies for the func-
tionality and well-being of ageing citizens to the ben-
efit of transformative and mission-oriented research 
and innovation agenda, is going beyond the traditional 
focus on the scientific impact of research. On the con-
trary, it emphasizes societal impacts, structuring im-
pacts on policymaking and policies as well as impacts 
on innovation and economy.
Ageing and Health System  
Sustainability
Equally complex as biological ageing is defining 
and promoting actions towards filling societal needs 
caused by ageing processes. Apart from the need to 
bridge biomedicine and social sciences, it is important 
to focus on a macro, mezzo, and micro level scope 
when investigating ageing phenomena.
By thinking strategically, we must clearly distinguish 
a) strategies aimed at the individual level to slow down 
ageing in the biological system and b) strategies aimed 
at the population level to define and pursue societal 
initiatives and policy changes to establish clear and ef-
fective approaches to address the public health impacts 
of an ageing society.
Today, we are facing healthcare challenges as the re-
sult of the rising and potentially unsustainable health 
and care costs, due to the increasing prevalence of 
chronic non-communicable diseases, to an ageing 
population requiring more diversified care and to in-
creasing societal demands.
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Most health services and health systems are well de-
signed to cure acute conditions or symptoms and tend 
to manage health issues in disconnected and frag-
mented ways. Lack of coordination across care provid-
ers and health services settings as well as not optimal 
time-management could be especially dangerous for 
organizing optimal care for older persons. Health sys-
tems need to be transformed so that they can ensure 
affordable access to evidence-based medical interven-
tions and timely organized shared care to address 
older people with specific needs according to their so-
cial determinants of health.
Health care and social care should be connected. 
The single disease model of care should be replaced by 
a more holistic approach where older people with mul-
tiple conditions are managed by a team of specialists 
and where the geriatricians are at the centre of deliver-
ing care, involved in much earlier stage. It is the only 
way by which health care can prevent further health 
deterioration, disability and prevent complicated care 
dependency later in life.
We recognize an urgent need to define clear goals, 
both for caretakers and caregivers. What are the ex-
pected outcomes? For a person impaired by joint pain, 
healthy ageing should focus on “active ageing”, while 
for a socially isolated person, it should include an ele-
ment of community and social involvement. A retired 
person who is feeling superfluous should be able to at-
tend a supportive programme to facilitate the transi-
tion from work to retirement, and one who is diag-
nosed with dementia should get adequate and quality 
support to better manage with this specific condition.
We often ask ourselves the following questions: Are 
we attempting only to promote longevity without an 
increase in the quality of life? Or are we also concerned 
with reducing costs linked to ageing? What are the 
final goals and measures that will tell us whether the 
users of our healthy ageing programs are successfully 
treated? However, there is no healthy longevity with-
out an increase in quality of life on all stages.
Considering this idea, our health systems will need 
to become more aligned with the needs of an older 
population with the introduction of special programs 
to prevent the onset of diseases. The focus of the health 
service provision needs to shift from treating illness in 
clinical settings to preventing it by integrating care to 
include health promotion activities, and by including 
the often-overlooked mental health services, as well as 
non-clinical and non-pharmacological interventions, 
such as community and social services, as well as self-
care practices. This would bring us closer to achieving 
a healthier population with an improved quality of life, 
which is one of the fundamental goals of a health care 
system.
We recognize a need for coordination among differ-
ent caregivers as a prerequisite to offer complete care 
and this is a natural and logical complement to inte-
grated care. Creating age-friendly environments re-
quires actions to combat ageism and abuse, enable au-
tonomy, and support healthy ageing in all policies and 
at all levels of government.
An integrated approach to ageing targeted at all the 
segments of health care is also likely to reduce the need 
for an expensive, interventionist hospital to be used 
most intensively in the senior population and particu-
larly at the end of life care, thereby reducing costs. As 
health includes more than medicine, the integration of 
non-pharmacological, self-care interventions with 
medical services in the care of the senior and pre-se-
nior population would improve the efficiency and sus-
tainability of health care systems that are continuously 
facing increased costs partly precipitated by extended 
ageing demands and increased costs of advanced 
health care technologies.
While limiting cost is one approach to ensuring the 
sustainability of the health system faced with the chal-
lenge of extended ageing, creating innovative funding 
schemes to address differing needs caused by ageing is 
also important and a challenging prospect that re-
quires a different perspective. When making policy 
recommendations, national governments need to con-
sider the implications of these on general health, in-
cluding healthy ageing, as defined by the WHO frame-
work for country action.
The promotion of healthy ageing will have massive 
implications not only on health care costs but also on 
the quality of life for older persons. Every person – in 
every country in the world – should have the opportu-
nity to live a long and healthy life. Yet, the environ-
ments in which we live can favour health or be harm-
ful to it.
The quality of the living environment and spatial 
epidemiology plays an important role in defining the 
health risks of the population. Especially in the face of 
rapid urbanization which is considered an important 
contributor to the growing burden of mental health 
across European and world populations. Equitable ac-
cess to high-quality green spaces, in the light of new 
research as well as Sustainable Development Goals, 
becomes an issue of environmental justice and highly 
policy-relevant approach in the endeavour to mitigate 
the negative effects of ageing in the urbanized world. 
Another important factor is accessibility to quality 
health regardless of social determinants of health and 
other sources of vulnerability. These issues became 
more and more apparent when considering the ageing 
of the population. Healthy ageing is about creating the 
socio-ecological climate and opportunities that enable 
people to be and do what they value throughout their 
lives.
Active and healthy ageing is a societal challenge 
shared by all European and other countries of the 
157
Policy Paper 2020; godište 142; supplement 1; 153–158 LIJEČ VJESN
world, but it is also an opportunity. It is important to 
acknowledge that the EU and European governments 
can learn from the experience of other countries the 
evidenced-based changes most effective in transform-
ing their health systems to adjust to the growth of age-
ing populations. At the same time, governments with-
in the EU can learn from each other as well. To that 
end, the EU and individual governments would be 
well to consider sustainable mechanisms to exchange 
data and learnings in this regard. It is a chance for Eu-
rope to establish itself as a global leader that can pro-
vide innovative solutions. Considering the current 
context, it is essential to take the lessons from the 
Coronavirus disease (COVID-19) pandemic which 
has particularly high fatality rates among very old peo-
ple, notably those living in residential care, and chron-
ic patients. It outlines the importance of disease pre-
vention using hygiene measures, well known long-ago. 
It also has shown us all the importance of every per-
son’s involvement in creating a healthy environment, 
healthy relationships and the importance of mental 
health, building solidarity, and social awareness of 
health needs of those who are in danger, especially se-
nior citizens. The WHO Decade of Healthy Ageing 
(2020–2030) is offering a unique opportunity to make 
this narrative a true reality for older persons, their 
families, and communities.
The scientific multidimensional concept of healthy 
ageing is defined as the process of developing and 
maintaining the functional ability that enables well-
being in older age. As people age, their health needs 
tend to become more complex determined by specific 
health issues and specific health demands of older 
 patients.
Therefore, the following issues need to be included as 
research areas in future research funding and planning 
through different European Commission research fund-
ing schemes in order to reduce mortality and morbidity 
of different age-related diseases:
 1.  Translational research into brain diseases will 
improve insight into the basic functioning of the 
brain.
 2.  Research into causal relationships and mecha-
nisms that can reduce and prevent frailty syn-
drome in the older population.
 3.  Research into repercussions of neurological and 
mental health conditions on society as a whole.
 4.  Research into sleep disorders strongly associated 
with age.
 5.  Special emphasis should be put on the research of 
gender, income, and geographically related differ-
ences in the burden of disease in the older popula-
tion and public health research into health pro-
motion and disease prevention of age-related 
conditions.
 6.  Research in novel AI and IT solutions that can 
help in promoting health, preventing disease and 
alleviating in the burden of disease in age-related 
conditions and improve health in the older popu-
lation.
 7.  Research on factors and causes that are connect-
ed with the issues of polypharmacy and concrete 
ways to prevent mortality and morbidity that is 
related to it especially in the older population. 
(DIRECTORATE-GENERAL SANTE is respon-
sible for EU policy on food safety and health and 
for monitoring the implementation of related 
laws. Through its scope of action together with 
the European medicines Agency (EMA) can play 
an important role in the implementation of suc-
cessful policies related to polypharmacy.)
 8.  Develop EU-wide coordinating mechanisms to 
increase the speed, efficiency and effectiveness of 
clinical trials and establish clinical testing for 
drugs targeting ageing in older patients with mul-
tiple chronic conditions (Here the European med-
icines Agency (EMA) can play an important role 
by introducing policies that will support the test-
ing in clinical trials with a new class of drugs and 
integrate their use with existing public health in-
terventions are required.)
 9.  Project for education and training of both care-
takers and caregivers in issues related to specific 
conditions related to ageing should be introduced 
and funded through EU funding schemes.
10.  Projects that are oriented to reducing vulnerabil-
ity and improving resilience, reducing social iso-
lation and promoting social inclusion of older 
populations across EU also those projects that are 
oriented to healthy urban planning should be in-
troduced and funded through EU funding 
schemes.
11.  Support sustainable mechanisms within the EU 
and between the EU countries and other coun-
tries to exchange data and learnings regarding 
the most effective evidence-based practices and 
innovations needed to transform national health 
systems in a manner best suited to prevent, treat 
and care for the chronic and social conditions af-
fecting the health and well-being of older popula-
tions.
12.  Finally, within the European Commission the fol-
lowing issues should be addressed and discussed:
a)  Is there a need to agree on the EU level for 
creation for Pan European Policies that will 
define the minimum standard of social care 
and health care to all European citizens’ espe-
cially older population? This will entail the 
creation of a special fund that can help reduce 
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inequality across different age groups and dif-
ferent EU member states.
b)  In the light of COVID-19 pandemic which 
has particularly high fatality rates among 
very old people, notably those living in resi-
dential care and chronic patients to come to 
an agreement on the EU level for creation for 
Pan European Policies that can in the future 
help in better coordination of rapid response 
among EU members states that will be based 
on the principle of solidarity and subsidiary 
in emergencies taking into account specific 
needs of each EU member state?
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